CLINICAL OPERATIONS:
Clinical Operations is responsible for the execution of all Phase 1-4 clinical trials, across all therapeutic areas, around the world. In partnership with Clinical Research, Medical Affairs and Development Operations functions, ensures that all clinical trial activities are performed in accordance with all applicable SOPs, company policies and regulatory guidelines to provide timely delivery of high quality clinical data to support global registration and commercialization of Gilead’s products.
Senior Clinical Trials Manager, Clinical Operations- Oncology (Sr. CTM)
We are seeking a talented, experienced, and highly motivated candidate to join the Oncology Clinical Operations team. The candidate must have the ability to work independently, be an effective leader, and an engaged team member in a dynamic, fast-paced environment.
**This position can be located in Foster City, CA, Morris Plains, NJ, or Seattle, WA or remotely in the US. Office based is preferred.
Specific Responsibilities and Skills for Position:
Ability to write study protocols, study reports, sections for investigator brochures and regulatory documents (e.g. IND, NDA, etc.) with little supervision
In partnership with CPMs, provides guidance and daily oversight for the successful management of all aspects of international clinical trials within designated program budgets and timelines
Communicates with functional peers regarding project status and issues and ensure project team goals are met
Must be able to resolve problems using national and international regulations, guidelines, and investigator interaction
Provide guidance and training to CROs, vendors, investigators and study coordinators on study requirements
Anticipates obstacles and client difficulties and implements solutions to achieve project goals
Experience in developing RFPs and selection and management of CROs/vendors
May contribute to development of abstracts, presentations and manuscripts
Functional expertise to initiate, author or contribute to SOP development, implementation and training
Participates in the recruiting and hiring process for CPA/CTMAs and supports their professional development
May manage CPA/CTMA/Sr. CTMA
Coaches members of a work team and ensures adherence to established guidelines
Ability to examine functional issues from a broader organizational perspective
Excellent interpersonal skills and demonstrated ability to lead is required
Independently manages less complex studies
Travel may be required
Knowledge:
Knowledge of FDA and/or EMA Regulations (or relevant local regulations), ICH Guidelines, and GCP governing the conduct of clinical studies
Working knowledge and experience with Word, PowerPoint and Excel
Excellent interpersonal skills and demonstrated ability to lead is required
Excellent verbal, written, interpersonal and presentation skills are required
Strong communication and influence skills and ability to create a clear sense of direction is necessary
Experience and Skills:
At least 6+ years of experience and a RN (2 or 3 year certificate) or BS/BA in a relevant scientific discipline
At least 4+ years of experience and a Masters' degree or higher; scientific discipline preferred
Prior Oncology experience is preferred
Foster City, CA
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. The company’s products include Biktarvy, Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Atripla, and Truvada for the treatment of human immunodeficiency virus (HIV) infection in adults; and Vosevi, Vemlidy, Epclusa, Harvoni, and Viread products for treating liver diseases.
It also provides Yescarta, a chimeric antigen receptor T cell therapy for adult patients with relapsed or refractory large B-cell lymphoma; Zydelig, a kinase inhibitor; Letairis, an oral formulation of an endothelin receptor antagonist for pulmonary arterial hypertension; Ranexa, a tablet to treat chronic angina; and AmBisome, an antifungal agent to treat serious invasive fungal infections. In addition, the company offers its products under the name Cayston, Emtriva, Hepsera, Sovaldi, and Tybost. Further, it develops product candidates for the treatment of HIV/AIDS and liver diseases, hematology/oncology, inflammation/respiratory diseases, and others.
The company markets its products through its commercial teams; and in conjunction with third-party distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements with Bristol-Myers Squibb Company; Janssen Sciences Ireland UC; Japan Tobacco Inc.; Galapagos NV; Scholar Rock Holding Corporation; Tango Therapeutics; National Cancer Institute; Pfizer, Inc.; Sangamo Therapeutics, Inc.; Gadeta B.V.; HiFiBiO Therapeutics; Agenus Inc.; HOOKIPA Pharma Inc.; Goldfinch Bio, Inc.; and insitro Inc. The company was founded in 1987 and is headquartered in Foster City, California.